Matei et al. report 39% of ovarian tumors to be PDGFR-α positive and inhibition of the PDGF-PDGFFR axis with imatinab restricted ovarian cancer cell growth in vitro (35, 37). This evidence concerns the gene PDGFRA and ovarian cancer.